The expanded collaboration between BRAIN Biotech and PX Group is a key part of the PX Urban Mining Initiative, an industry and academic network focused on developing and implementing disruptive, ...

Scientists recorded increase brain activity just before the patient died. What happens to the human brain as people are on the precipice of death is an enigma that has perplexed ordinary folks and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Pipeline and key clinical candidates for these ...

Fidelity Advisor Biotechnology Fund earns an Above Average Process Pillar rating. The most important driver of the rating is its parent firm's superior long-term risk-adjusted performance ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the ...

President Droupadi Murmu is scheduled to visit Prayagraj on Monday to participate in the ongoing Maha Kumbh festivities, where she will take a sacred dip at the Triveni Sangam. The President will ...

Chandler officers responded to a welfare check near Dobson and Germann Roads where they found two bodies inside a home. Florence police say the victim, Justin Miller, and his girlfriend were being ...

About half of the assets typically reside in companies with innovative therapies in the biotech and pharmaceutical industries, with the remainder in steadier medical device and services stocks.

LONDON, February 04, 2025-- Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today released the following regular monthly Net Asset Value (NAV) and Performance Report for the month of January 2025.

The nation must lose its tight focus on individual disciplines if it is to keep pace with the evolving requirements of scientific enquiry.

New! Sign up for our free email newsletter.

The Fund invests in shares of listed companies, principally in the biotechnology, genomic and medical research industry, which the Manager believes will provide above-average returns. The Fund invests ...